Bryan E. Smith

Insider Reports History

Location
Irvine, CA
Signature
/s/ Paul Little, as attorney-in-fact for Bryan Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bryan E. Smith:

Company Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. General Counsel, Corporate Sec Stock Option (right to buy) 150,500 10 Jan 2025 Direct
Eledon Pharmaceuticals, Inc. General Counsel, Corporate Sec Restricted Stock Units 64,500 10 Jan 2025 Direct

Insider Reports Filed by Bryan E. Smith

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ELDN Eledon Pharmaceuticals, Inc. 10 Jan 2025 2 $0 4 General Counsel, Corporate Sec 13 Jan 2025, 17:30
ELDN Eledon Pharmaceuticals, Inc. 21 Nov 2024 1 $0 4 General Counsel, Corporate Sec 22 Nov 2024, 17:00
ELDN Eledon Pharmaceuticals, Inc. 13 Jun 2024 1 $0 4 General Counsel, Corporate Sec 14 Jun 2024, 17:00
ELDN Eledon Pharmaceuticals, Inc. 01 May 2023 1 $0 4 General Counsel, Corporate Sec 02 May 2023, 18:50
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2023 1 $0 4 General Counsel, Corporate Sec 02 Feb 2023, 16:43
ELDN Eledon Pharmaceuticals, Inc. 01 Feb 2022 1 $0 4 General Counsel, Corporate Sec 02 Feb 2022, 16:37